Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia
Fernando A. Fierro(University of Salerno), Martin Bornhäuser(Technische Universität Dresden), Sebastian Brenner(University Hospital Carl Gustav Carus), Thomas Illmer(Center for Systems Biology Dresden), Angela Jacobi(University Hospital Carl Gustav Carus), Gerhard Ehninger(University Hospital Carl Gustav Carus), Holger Knoth(Technische Universität Dresden), Uta Oelschlaegel(University Hospital Carl Gustav Carus)
Cited by 30
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
|Leukemia|2011|398